These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 34927338)
21. In vitro effects of PI3K/mTOR inhibition in canine hemangiosarcoma. Pyuen AA; Meuten T; Rose BJ; Thamm DH PLoS One; 2018; 13(7):e0200634. PubMed ID: 30011343 [TBL] [Abstract][Full Text] [Related]
22. Therapeutic potential of endothelin inhibitors in canine hemangiosarcoma. Fukumoto S; Saida K; Sakai H; Ueno H; Iwano H; Uchide T Life Sci; 2016 Aug; 159():55-60. PubMed ID: 26835989 [TBL] [Abstract][Full Text] [Related]
23. Use of routine histopathology and factor VIII-related antigen/von Willebrand factor immunohistochemistry to differentiate primary hemangiosarcoma of bone from telangiectatic osteosarcoma in 54 dogs. Giuffrida MA; Bacon NJ; Kamstock DA Vet Comp Oncol; 2017 Dec; 15(4):1232-1239. PubMed ID: 27507032 [TBL] [Abstract][Full Text] [Related]
24. Characterizing circulating nucleosomes in the plasma of dogs with hemangiosarcoma. Wilson-Robles H; Miller T; Jarvis J; Terrell J; Kelly TK; Bygott T; Bougoussa M BMC Vet Res; 2021 Jun; 17(1):231. PubMed ID: 34187493 [TBL] [Abstract][Full Text] [Related]
25. Identification of genomic alterations with clinical impact in canine splenic hemangiosarcoma. Estabrooks T; Gurinovich A; Pietruska J; Lewis B; Harvey G; Post G; Lambert L; Miller A; Rodrigues L; White ME; Lopes C; London CA; Megquier K Vet Comp Oncol; 2023 Dec; 21(4):623-633. PubMed ID: 37734854 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma. U'Ren LW; Biller BJ; Elmslie RE; Thamm DH; Dow SW J Vet Intern Med; 2007; 21(1):113-20. PubMed ID: 17338158 [TBL] [Abstract][Full Text] [Related]
27. Expression of platelet-derived growth factor and its receptors in spontaneous canine hemangiosarcoma and cutaneous hemangioma. Asa SA; Murai A; Murakami M; Hoshino Y; Mori T; Maruo K; Khater A; El-Sawak A; el-Aziz EA; Yanai T; Sakai H Histol Histopathol; 2012 May; 27(5):601-7. PubMed ID: 22419024 [TBL] [Abstract][Full Text] [Related]
28. Histone demethylase KDM2B upregulates histone methyltransferase EZH2 expression and contributes to the progression of ovarian cancer in vitro and in vivo. Kuang Y; Lu F; Guo J; Xu H; Wang Q; Xu C; Zeng L; Yi S Onco Targets Ther; 2017; 10():3131-3144. PubMed ID: 28706445 [TBL] [Abstract][Full Text] [Related]
29. Correlation between thoracic radiographs and postmortem findings in dogs with hemangiosarcoma: 77 cases (1984-1989). Holt D; Van Winkle T; Schelling C; Prymak C J Am Vet Med Assoc; 1992 May; 200(10):1535-9. PubMed ID: 1612998 [TBL] [Abstract][Full Text] [Related]
30. Efficacy and toxicity of a dose-intensified doxorubicin protocol in canine hemangiosarcoma. Sorenmo KU; Baez JL; Clifford CA; Mauldin E; Overley B; Skorupski K; Bachman R; Samluk M; Shofer F J Vet Intern Med; 2004; 18(2):209-13. PubMed ID: 15058772 [TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical Detection of Urokinase Plasminogen Activator and Urokinase Plasminogen Activator Receptor in Canine Vascular Endothelial Tumours. Anwar Sh; Yanai T; Sakai H J Comp Pathol; 2015 Nov; 153(4):278-82. PubMed ID: 26286429 [TBL] [Abstract][Full Text] [Related]
32. Interleukin-8 promotes canine hemangiosarcoma growth by regulating the tumor microenvironment. Kim JH; Frantz AM; Anderson KL; Graef AJ; Scott MC; Robinson S; Sharkey LC; O Brien TD; Dickerson EB; Modiano JF Exp Cell Res; 2014 Apr; 323(1):155-164. PubMed ID: 24582862 [TBL] [Abstract][Full Text] [Related]
33. Doxorubicin and deracoxib adjuvant therapy for canine splenic hemangiosarcoma: a pilot study. Kahn SA; Mullin CM; de Lorimier LP; Burgess KE; Risbon RE; Fred RM; Drobatz K; Clifford CA Can Vet J; 2013 Mar; 54(3):237-42. PubMed ID: 23997259 [TBL] [Abstract][Full Text] [Related]
34. Primary colonic hemangiosarcoma in a dog. Iwata M; Aikawa T; Miyazaki Y; Sadahiro S Can Vet J; 2018 Apr; 59(4):373-378. PubMed ID: 29606722 [TBL] [Abstract][Full Text] [Related]
35. Clinical outcome in 94 cases of dermal haemangiosarcoma in dogs treated with surgical excision: 1993-2007*. Szivek A; Burns RE; Gericota B; Affolter VK; Kent MS; Rodriguez CO; Skorupski KA Vet Comp Oncol; 2012 Mar; 10(1):65-73. PubMed ID: 22236371 [TBL] [Abstract][Full Text] [Related]
36. Interplay between the Epigenetic Enzyme Lysine (K)-Specific Demethylase 2B and Epstein-Barr Virus Infection. Vargas-Ayala RC; Jay A; Manara F; Maroui MA; Hernandez-Vargas H; Diederichs A; Robitaille A; Sirand C; Ceraolo MG; Romero-Medina MC; Cros MP; Cuenin C; Durand G; Le Calvez-Kelm F; Mundo L; Leoncini L; Manet E; Herceg Z; Gruffat H; Accardi R J Virol; 2019 Jul; 93(13):. PubMed ID: 30996097 [TBL] [Abstract][Full Text] [Related]
37. Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial. Vail DM; MacEwen EG; Kurzman ID; Dubielzig RR; Helfand SC; Kisseberth WC; London CA; Obradovich JE; Madewell BR; Rodriguez CO Clin Cancer Res; 1995 Oct; 1(10):1165-70. PubMed ID: 9815908 [TBL] [Abstract][Full Text] [Related]
39. Comparison of doxorubicin-cyclophosphamide with doxorubicin-dacarbazine for the adjuvant treatment of canine hemangiosarcoma. Finotello R; Stefanello D; Zini E; Marconato L Vet Comp Oncol; 2017 Mar; 15(1):25-35. PubMed ID: 25623994 [TBL] [Abstract][Full Text] [Related]
40. Canine malignant hemangiosarcoma as a model of primitive angiogenic endothelium. Fosmire SP; Dickerson EB; Scott AM; Bianco SR; Pettengill MJ; Meylemans H; Padilla M; Frazer-Abel AA; Akhtar N; Getzy DM; Wojcieszyn J; Breen M; Helfand SC; Modiano JF Lab Invest; 2004 May; 84(5):562-72. PubMed ID: 15064773 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]